Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells.

MLA

Murakami, Yuko, et al. “Dual Effects of the Nrf2 Inhibitor for Inhibition of Hepatitis C Virus and Hepatic Cancer Cells.” BMC Cancer, vol. 18, no. 1, June 2018, p. 680. EBSCOhost, https://doi.org/10.1186/s12885-018-4588-y.

APA

Murakami, Y., Sugiyama, K., Ebinuma, H., Nakamoto, N., Ojiro, K., Chu, P.-S., Taniki, N., Saito, Y., Teratani, T., Koda, Y., Suzuki, T., Saito, K., Fukasawa, M., Ikeda, M., Kato, N., Kanai, T., & Saito, H. (2018). Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells. BMC Cancer, 18(1), 680. https://doi.org/10.1186/s12885-018-4588-y

Chicago

Murakami, Yuko, Kazuo Sugiyama, Hirotoshi Ebinuma, Nobuhiro Nakamoto, Keisuke Ojiro, Po-Sung Chu, Nobuhito Taniki, et al. 2018. “Dual Effects of the Nrf2 Inhibitor for Inhibition of Hepatitis C Virus and Hepatic Cancer Cells.” BMC Cancer 18 (1): 680. doi:10.1186/s12885-018-4588-y.